Atezolizumab Plus Chemotherapy vs. Chemotherapy in Advanced or Metastatic Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis.

已完结 10 由 long 发布于 2024/7/2 22:13:43

DOI:10.3389/fpubh.2021.756899
作者：Xiaoyan Liu, Yitian Lang, Yahui Liao, Yizhun Zhu
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.3389/fpubh.2021.756899

Frontiers Media

Abstract：Purpose: The IMpassion130 trial demonstrated the efficacy of adding atezolizumab to paclitaxel for advanced or metastatic triple-negative breast cancer (TNBC). The current study evaluated th

应助信息

2024-07-03

姜姜姜

该信息应助已超过48小时，文件已经删除。如有需求，请重新发布求助。一键发布

2024-07-02

Book学术机器人

2024/7/2 22:13:43 未找到该文献，机器人已退出，请等待人工下载

2024/7/2 22:13:43 Book学术AI机器人收到请求，开始寻找文献

2024/7/2 22:13:43 已向机器人发送请求

2024-07-02

long 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Biochar Benefits Green Infrastructure: Global Meta-Analysis and Synthesis